Corvus Pharmaceuticals, Inc. (CRVS)

Recent filings

On September - Sept. 17, 2020

Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020

Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020

Departure of Directors or Certain - Sept. 11, 2020

On September - Sept. 10, 2020

Corvus Pharmaceuticals Provides Business Update And Reports Second Quarter 2020 Financial Results - July 30, 2020

Corvus Pharmaceuticals, Inc. Just Filed Its Quarterly Report: 3. Net Loss per Shar... - July 30, 2020

Major owner of Corvus Pharmaceuticals, Inc. just disposed of 1,538,062 shares - July 9, 2020

Novo Holdings A just provided an update on activist position in Corvus Pharmaceuticals, Inc. - July 9, 2020

On July - July 7, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 3,275,616 shares of Corvus Pharmaceuticals, Inc. - June 15, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 12, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 12, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 3,275,616 shares of Corvus Pharmaceuticals, Inc. - June 12, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 12, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 12, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 6,767,584 shares of Corvus Pharmaceuticals, Inc. - June 12, 2020

Submission of Matters to a Vote of Security - June 10, 2020

On May - May 29, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 2,927,560 shares of Corvus Pharmaceuticals, Inc. - May 6, 2020

Securities to be offered to employees in employee benefit plans - April 30, 2020

Corvus Pharmaceuticals Provides Business Update And Reports First Quarter 2020 Financial Results - April 30, 2020

Corvus Pharmaceuticals, Inc. Just Filed Its Quarterly Report: 3. Net Loss per S... - April 30, 2020

OrbiMed Capital GP V LLC just provided an update on activist position in Corvus Pharmaceuticals, Inc. - April 17, 2020

Corvus Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - April 15, 2020

Corvus Pharmaceuticals, Inc. releases salary data. CEO sees compensation fall -19% - April 15, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - March 23, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - March 23, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - March 23, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 3,275,616 shares of Corvus Pharmaceuticals, Inc. - March 23, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - March 23, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 3,275,616 shares of Corvus Pharmaceuticals, Inc. - March 23, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 6,767,584 shares of Corvus Pharmaceuticals, Inc. - March 23, 2020

Corvus Pharmaceuticals, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - March 20, 2020

Departure of Directors or Certain - March 20, 2020

Corvus Pharmaceuticals, Inc. Just Received a Notice of Effectiveness - March 19, 2020

Registration statement under Securities Act of 1933 - March 9, 2020

Corvus Pharmaceuticals, Inc. Just Filed Its Annual Report: Net Loss per Shar... - March 9, 2020

Corvus Pharmaceuticals Provides Business Update And Reports Fourth Quarter And Full Year 2019 Financial Results - March 5, 2020

Mark N. Lampert just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Feb. 18, 2020

Mark N. Lampert just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Feb. 14, 2020

T. ROWE PRICE ASSOCIATES, INC. just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Feb. 14, 2020

Corvus Pharmaceuticals Presents Updated Clinical Data From Its Phase 1B/2 Clinical Trial Of Ciforadenant At The 2020 American Society Of Clinical Oncology’S Genitourinary Cancers Symposium - Feb. 13, 2020

Sandra J. Horning just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Feb. 12, 2020

Corvus Pharmaceuticals Presents Updated Clinical Data From Its Phase 1/1B Clinical Trial Of Cpi-818 At The 12Th Annual T-Cell Lymphoma Forum - Feb. 3, 2020

Corvus Pharmaceuticals, Inc.'s Chief Financial Officer was just granted 160,000 options - Dec. 16, 2019

Departure of Directors or Certain - Dec. 16, 2019

Corvus Pharmaceuticals, Inc.'s President and CEO was just granted 320,000 options - Dec. 16, 2019

SVP of Corvus Pharmaceuticals, Inc. was just granted 75,000 options - Dec. 16, 2019

VP of Corvus Pharmaceuticals, Inc. was just granted 50,000 options - Dec. 16, 2019

Corvus Pharmaceuticals, Inc.'s See Remarks was just granted 160,000 options - Dec. 16, 2019

EVP of Corvus Pharmaceuticals, Inc. was just granted 40,000 options - Dec. 16, 2019

VP of Corvus Pharmaceuticals, Inc. was just granted 50,000 options - Dec. 16, 2019

Corvus Pharmaceuticals Presents Preclinical And Initial Clinical Data From The Phase 1/1B Trial Of Cpi-818 At The American Society Of Hematology (Ash) Annual Meeting - Dec. 9, 2019

Corvus Pharmaceuticals, Inc.'s President and CEO just picked up 15,008 shares - Nov. 14, 2019

Entry into a Material Definitive - Nov. 12, 2019

On November - Nov. 8, 2019

Corvus Pharmaceuticals Provides Business Update And Reports Third Quarter 2019 Financial Results - Oct. 29, 2019

Corvus Pharmaceuticals, Inc.'s President and CEO just picked up 7,500 shares - Aug. 8, 2019

Major owner of Corvus Pharmaceuticals, Inc. just picked up 142,656 shares - Aug. 8, 2019

Major owner of Corvus Pharmaceuticals, Inc. just picked up 142,656 shares - Aug. 8, 2019

Mark N. Lampert just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Aug. 7, 2019

Corvus Pharmaceuticals, Inc. Just Filed Its Quarterly Report: 3. Net Loss per S... - Aug. 1, 2019

Corvus Pharmaceuticals Provides Business Update And Reports Second Quarter 2019 Financial Results - Aug. 1, 2019

Novo Holdings A just provided an update on activist position in Corvus Pharmaceuticals, Inc. - July 29, 2019

Major owner of Corvus Pharmaceuticals, Inc. just disposed of 1,492,956 shares - July 25, 2019

OrbiMed Capital just provided an update on activist position in Corvus Pharmaceuticals, Inc. - July 2, 2019

Major owner of Corvus Pharmaceuticals, Inc. just picked up 657,344 shares - July 1, 2019

Major owner of Corvus Pharmaceuticals, Inc. just picked up 657,344 shares - July 1, 2019

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 24, 2019

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 24, 2019

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 24, 2019

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 5,967,584 shares of Corvus Pharmaceuticals, Inc. - June 24, 2019

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 3,275,616 shares of Corvus Pharmaceuticals, Inc. - June 24, 2019

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 3,275,616 shares of Corvus Pharmaceuticals, Inc. - June 24, 2019

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 24, 2019

Corvus Pharmaceuticals, Inc.'s President and CEO just picked up 12,000 shares - June 17, 2019

Corvus Pharmaceuticals, Inc.'s President and CEO just picked up 15,212 shares - June 11, 2019

Corvus Pharmaceuticals, Inc.'s Chief Financial Officer just picked up 25,500 shares - June 10, 2019

Securities to be offered to employees in employee benefit plans - May 9, 2019

Corvus Pharmaceuticals Provides Business Update And Reports First Quarter 2019 Financial Results - May 9, 2019

Corvus Pharmaceuticals, Inc. Just Filed Its Quarterly Report: 3. Net Loss per S... - May 9, 2019

Corvus Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - April 24, 2019

Corvus Pharmaceuticals, Inc. releases salary data. CEO sees compensation rise 8% - April 24, 2019

Corvus Pharmaceuticals, Inc. Just Filed Its Annual Report: Net Loss per Shar... - March 7, 2019

Corvus Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results And Provides Business Update - March 7, 2019

Mark N. Lampert just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Feb. 14, 2019

T. ROWE PRICE ASSOCIATES, INC. just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Feb. 14, 2019

Corvus Pharmaceuticals: Corvus Presents Updated Biomarker And Clinical Results From Lead Pipeline Programs Cpi-444 And Cpi-006 At Immuno-Oncology 360° Conference - Feb. 6, 2019

Novo Holdings A just provided an update on activist position in Corvus Pharmaceuticals, Inc. - Jan. 31, 2019

Corvus Pharmaceuticals, Inc.'s Chief Medical Officer just declared ownership of no shares of Corvus Pharmaceuticals, Inc. - Jan. 30, 2019

Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Jan. 30, 2019

Corvus Pharmaceuticals, Inc.'s Chief Medical Officer was just granted 210,000 options - Jan. 30, 2019

Corvus Pharmaceuticals, Inc. director just declared ownership of no shares of Corvus Pharmaceuticals, Inc. - Jan. 30, 2019

Corvus Pharmaceuticals Announces Appointment Of New Member Of Board Of Directors And Hiring Of Chief Medical Officer - Jan. 28, 2019

Corvus Pharmaceuticals: Corvus Announces Presentation Of Preclinical Data On Cpi-818, A First-In-Class Covalent Inhibitor Of Itk Targeting T-Cell Lymphomas - Jan. 10, 2019

Corvus Pharmaceuticals: Corvus Announces Enrollment In Second Arm Of Phase 1/1B Dose-Escalation Trial Of Anti-Cd73 Antibody, Cpi-006, Focused On Combination With Cpi-444 Adenosine Antagonist - Jan. 8, 2019

Corvus Pharmaceuticals, Inc.'s President and CEO just picked up 20,000 shares - Dec. 31, 2018

Corvus Pharmaceuticals, Inc.'s Chief Financial Officer just picked up 24,700 shares - Dec. 27, 2018

Corvus Pharmaceuticals, Inc.'s President and CEO just picked up 10,000 shares - Dec. 26, 2018

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. ADAMS STREET PARTNERS LLC 3,275,616 1.9 June 30, 2020
2. Novo A/S 2,927,560 0.5 June 30, 2020
3. ORBIMED ADVISORS LLC 6,767,584 0.3 June 30, 2020
4. BVF INC/IL 1,742,112 0.3 June 30, 2020
5. EcoR1 Capital, LLC 737,612 0.2 June 30, 2020
6. COWEN GROUP, INC. 576,231 0.1 June 30, 2019
7. EverPoint Asset Management, LLC 417,849 0.1 Dec. 31, 2016
8. BlackRock Fund Advisors 92,852 N/A Sept. 30, 2016
9. TEACHERS ADVISORS INC 22,433 N/A March 31, 2019
10. UBS Group AG 5,525 N/A March 31, 2019
11. TWO SIGMA INVESTMENTS LLC 50,776 N/A June 30, 2020
12. UBS Group AG 5,525 N/A March 31, 2019
13. Squarepoint Ops LLC 26,418 N/A June 30, 2020
14. BlackRock Group LTD 5,062 N/A Sept. 30, 2016
15. BlackRock Institutional Trust Company, N.A. 36,583 N/A Dec. 31, 2016
16. MILLENNIUM MANAGEMENT LLC 1,031,759 N/A March 31, 2020
17. MORGAN STANLEY 9,971 N/A Dec. 31, 2016
18. CITIGROUP INC 1 N/A Sept. 30, 2017
19. WELLS FARGO & COMPANY/MN 3,982 N/A Sept. 30, 2018
20. DEUTSCHE BANK AG\ 19,058 N/A Dec. 31, 2017
21. DIMENSIONAL FUND ADVISORS LP 438,383 N/A June 30, 2020
22. MEEDER ASSET MANAGEMENT INC 608 N/A June 30, 2020
23. GOLDMAN SACHS GROUP INC 27,103 N/A March 31, 2019
24. Connor, Clark & Lunn Investment Management Ltd. 84,918 N/A June 30, 2020
25. TWO SIGMA ADVISERS, LLC 36,880 N/A June 30, 2020
26. ACADIAN ASSET MANAGEMENT LLC 181,755 N/A June 30, 2020
27. BlackRock Japan Co. Ltd 835 N/A Sept. 30, 2016
28. BANK OF AMERICA CORP /DE/ 391 N/A Sept. 30, 2017
29. KCG Holdings, Inc. 17,606 N/A June 30, 2017
30. Manchester Capital Management LLC 215 N/A March 31, 2020
 


Feedback